Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991008734) ANHYDROUS OIL-BASED LIQUID SUSPENSION FOR DELIVERING A MEDICAMENT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/008734 International Application No.: PCT/US1990/003250
Publication Date: 27.06.1991 International Filing Date: 08.06.1990
Chapter 2 Demand Filed: 27.11.1990
IPC:
A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
ABBOTT LABORATORIES [US/US]; CHAD 0377/AP6D-2 One Abbott Park Road Abbott Park, IL 60064-3500, US (AllExceptUS)
ADJEI, Akwete, L. [US/US]; US (UsOnly)
BORODKIN, Saul [US/US]; US (UsOnly)
DOYLE, Richard, B. [US/US]; US (UsOnly)
Inventors:
ADJEI, Akwete, L.; US
BORODKIN, Saul; US
DOYLE, Richard, B.; US
Agent:
GORMAN, Edward, Hoover, Jr. ; Abbott Laboratories CHAD-0377/AP6D-2 One Abbott Park Road Abbott Park, IL 60064-3500, US
Priority Data:
365,40913.06.1989US
Title (EN) ANHYDROUS OIL-BASED LIQUID SUSPENSION FOR DELIVERING A MEDICAMENT
(FR) SUSPENSION LIQUIDE ET ANHYDRE A BASE D'HUILE SERVANT A LIBERER UN MEDICAMENT
Abstract:
(EN) Oil-based non-aqueous liquid suspension drug delivery vehicles, suitable for the administration of drugs which are sensitive to water or which have an unpalatable taste comprise an edible oil, a sugar, and a suspending agent. The average particle size of all solid components of the formulation is 30 $g(m) or less which results in formulations which have excellent physical stability including resistance to particle agglomeration, settling and caking.
(FR) Supports de libération de médicaments sous forme de suspension liquide et non aqueuse à base d'huile, aptes à libérer des médicaments sensibles à l'eau ou ayant un goût désagréable, et comprenant une huile comestible, un sucre et un agent de suspension. La taille moyenne des particules de tous les constituants solides de la formulation est égale ou inférieure à 30 $g(m), ce qui permet d'obtenir des formulations qui présentent une stabilité physique excellente, c'est-à-dire par exemple une résistance à l'agglomération particulaire, à la sédimentation et à l'agglutination.
Designated States: AU, CA, JP, KR, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
IL94710EP0477289CA2060501PT94372KR1019920702616AU1990059342